Neuberger Berman Group
CDLX icon

Neuberger Berman Group’s Cardlytics CDLX Stock Holding History

Neuberger Berman Group’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-4,490
Closed -$5.69M – 1772
2021
Q2 		$5.69M Sell
4,490
-1,353
-23% -$1.53M 0.01% 927
2021
Q1 		$6.41M Buy
5,843
+2,683
+85% +$3.54M 0.01% 907
2020
Q4 		$4.51M Sell
3,160
-3,940
-55% -$4.2M ﹤0.01% 926
2020
Q3 		$5.01M Buy
7,100
+4,900
+223% +$3.56M 0.01% 855
2020
Q2 		$1.54M Sell
2,200
-2,200
-50% -$1.27M ﹤0.01% 1062
2020
Q1 		$1.54M Buy
4,400
+100
+2% +$70.8K ﹤0.01% 1002
2019
Q4 		$2.7M Buy
4,300
+130
+3% +$63.6K ﹤0.01% 964
2019
Q3 		$1.4M Buy
+4,170
New +$1.34M ﹤0.01% 1080

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
ACM
Alua Capital Management New York $1.13B AUM 8.41% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Neuberger Berman Group's CDLX Position: Q3 2021 in Review

Neuberger Berman Group sold out of Cardlytics (CDLX) in Q3 2021, closing a stake of 4,490 shares — an estimated $5.69M sold.

Neuberger Berman Group first reported a position in CDLX in Q3 2019 and held it in 8 quarters. The position peaked at $6.41M in Q1 2021. 164 funds tracked by Wall St. Rank hold CDLX as of Q3 2021.

  • Neuberger Berman Group reported no remaining Cardlytics position as of Q3 2021 after selling out during the quarter.
  • Neuberger Berman Group sold 4,490 Cardlytics shares in Q3 2021, an estimated $5.69M.
  • Neuberger Berman Group first reported a position in Cardlytics in Q3 2019 and held it in 8 quarters.
  • Neuberger Berman Group's Cardlytics position peaked at $6.41M in Q1 2021.
  • 164 funds tracked by Wall St. Rank held Cardlytics as of Q3 2021.

Based on Neuberger Berman Group's 13F filing for Q3 2021, filed 12 Nov 2021.